Anastomosis Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Disposable, Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others), By End-use (Hospitals, Ambulatory Care Centers & Clinics), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 62.23 Million
CAGR (2026-2031)	5.89%
Fastest Growing Segment	Disposable
Largest Market	North America
Market Size (2031)	USD 87.73 Million

Market Overview

The Global Anastomosis Devices Market will grow from USD 62.23 Million in 2025 to USD 87.73 Million by 2031 at a 5.89% CAGR. Anastomosis devices are specialized surgical instruments designed to establish a connection between two distinct sections of tubular structures, such as blood vessels or intestines, following a resection. The market is primarily supported by the rising prevalence of chronic conditions, particularly cardiovascular diseases and gastrointestinal cancers, which necessitate complex surgical interventions. Furthermore, the global expansion of the geriatric population serves as a foundational driver. These factors are distinct from temporary market trends, representing sustained demand for effective tissue approximation solutions.

However, the market faces a significant impediment regarding the risk of post-operative complications, particularly anastomotic leaks, which can lead to severe patient morbidity and increased healthcare costs. This clinical challenge necessitates rigorous regulatory scrutiny and surgeon training, potentially slowing adoption rates. Illustrating the substantial burden of disease requiring these interventions, according to the American Cancer Society, in 2025, an estimated 154,270 new cases of colorectal cancer were projected in the United States.

Key Market Drivers

Integration of robotic-assisted technologies in surgical anastomosis serves as a primary driver for market expansion, fundamentally altering how complex reconstructions are performed. The shift toward robotic platforms enables surgeons to execute precise vascular and intestinal connections with enhanced dexterity, significantly reducing the risk of manual errors and anastomotic leaks. This technological transition necessitates the adoption of specialized, automated anastomosis devices compatible with robotic arms, thereby fueling segment growth. Validating this trend of increased robotic procedural volume, according to Intuitive Surgical, January 2025, in the 'Preliminary Fourth Quarter and Full Year 2024 Results', worldwide da Vinci procedures grew approximately 17% in 2024 compared to the previous year.

Simultaneously, the increasing global incidence of cardiovascular and gastrointestinal disorders is propelling the volume of surgical interventions requiring tissue approximation. As the prevalence of conditions such as colorectal cancer and ischemic heart disease rises, healthcare providers are compelled to increase surgical capacity, directly boosting the consumption of staples, sutures, and sealants. This surging demand is evident in the performance of major industry players; according to Medtronic, November 2025, in the 'Second Quarter Fiscal 2026 Financial Results', the Cardiovascular portfolio achieved its strongest revenue growth in over a decade, excluding the impact of the pandemic. Reflecting the broader momentum in surgical device utilization, according to Johnson & Johnson, October 2025, in the 'Third Quarter 2025 Financial Results', the MedTech segment reported worldwide sales of $8.4 billion, representing a 6.8% increase.

Download Free Sample Report

Key Market Challenges

The risk of post-operative complications, particularly anastomotic leaks, presents a formidable barrier to the expansion of the Global Anastomosis Devices Market. These adverse events significantly impede market growth by necessitating stringent regulatory validations and elevating the threshold for clinical evidence required before new devices can be commercialized. When surgical resections result in leakage, the associated rise in patient morbidity and liability concerns causes healthcare providers to approach the adoption of newer, complex anastomosis technologies with considerable caution, thereby lengthening sales cycles.

This challenge is quantitatively significant within the industry. According to the European Society of Coloproctology, in 2025, published international audit data indicated a 30-day anastomotic leak rate of approximately 7.96% in patients undergoing colorectal surgery. Such persistent complication rates reinforce the hesitation among surgical teams to transition away from established manual techniques or trusted legacy devices. Consequently, the high burden of care associated with repairing leaks diverts healthcare resources, limiting the budget available for premium anastomosis instrumentation and restricting immediate market volume expansion.

Key Market Trends

The adoption of sutureless magnetic compression anastomosis is fundamentally reshaping the market by offering an incisionless alternative to traditional stapling, particularly for gastrointestinal reconstructions. This technology utilizes self-aligning magnetic rings to compress tissue, inducing necrosis and creating a secure, patent anastomosis while naturally eliminating foreign materials from the body. The expansion of this segment is driven by the need to mitigate anastomotic leaks and reduce the trauma associated with mechanical fasteners. Validating the rapid commercial maturation of this technology, according to GT Metabolic Solutions, March 2025, in the 'GT Metabolic Expands MagDI System with FDA clearance of 50mm magnet' press release, the company received regulatory clearance for a larger 50mm magnet to complement its existing portfolio, significantly broadening the range of patient anatomies eligible for this staple-free technique.

Simultaneously, the advancement in smart and powered stapling technologies is accelerating, characterized by the integration of intelligent feedback mechanisms that optimize firing force and staple formation in real-time. As surgical volumes rise, manufacturers are prioritizing devices that reduce user variability and ensure consistent tissue compression across varying thicknesses, a critical factor in preventing post-operative failures. This shift towards intelligent instrumentation is directly supported by the projected increase in procedural demand; according to Intuitive Surgical, January 2025, in the 'Preliminary Fourth Quarter and Full Year 2024 Results' press release, the company anticipates a 13% to 16% increase in worldwide procedure volume for 2025, creating a substantial market requirement for advanced, automated stapling solutions capable of supporting high-throughput surgical environments.

Segmental Insights

In the Global Anastomosis Devices Market, the disposable segment is recognized as the fastest-growing category due to increasing concerns regarding patient safety and infection control. Healthcare facilities are shifting toward single-use devices to eliminate the risks of cross-contamination often associated with reprocessing reusable instruments. Regulatory authorities, such as the U.S. Food and Drug Administration, have heightened scrutiny regarding the sterilization of complex surgical tools, prompting a transition to disposables to minimize surgical site infections. This preference for single-use options ensures consistent performance and compliance with stringent hygiene standards, driving the segment's expansion.

Regional Insights

North America maintains a dominant position in the global anastomosis devices market, primarily driven by the rising prevalence of cardiovascular and gastrointestinal conditions requiring surgical repair. The region possesses a well-established healthcare infrastructure and comprehensive reimbursement frameworks that facilitate patient access to necessary surgical procedures. Additionally, the concentration of key industry manufacturers within the United States strengthens local market growth. Strict regulatory oversight by the US Food and Drug Administration further supports market stability by ensuring that devices meet rigorous safety and efficacy standards before commercialization.

Recent Developments

• In November 2025, Medtronic announced the limited commercial release of the Signia Circular Stapler featuring Tri-Staple technology. This new system was introduced as the first intelligent circular stapling solution capable of being used throughout the alimentary tract for creating end-to-end and side-to-side anastomoses in both open and laparoscopic surgeries. The device integrates powered clamping with real-time feedback mechanisms to reduce stress on tissue and improve perfusion at the staple line. The Vice President of Core Surgical Innovations at Medtronic emphasized that the technology was designed to standardize surgical performance and minimize the risk of anastomotic leaks, thereby supporting improved patient recovery outcomes.
• In April 2025, Intuitive Surgical received 510(k) clearance from the U.S. Food and Drug Administration for the SureForm 45 stapler, explicitly designed for use with the da Vinci SP surgical system. This approval marked the availability of the first stapler specifically engineered for a single-port robotic platform in the United States market. The device incorporates SmartFire technology, which automatically monitors tissue compression and adjusts the firing cycle to ensure consistent staple line integrity across varying tissue thicknesses. The Chief Medical Officer of Intuitive Surgical noted that this advancement allows surgeons to maintain autonomy and precision directly from the console during complex urologic, thoracic, and colorectal procedures.
• In October 2024, GT Metabolic Solutions announced that the U.S. Food and Drug Administration granted clearance for its MagDI System, a novel magnetic compression anastomosis device. This regulatory milestone facilitated the commercial introduction of a sutureless, incisionless method for creating side-to-side duodeno-ileal anastomoses. The system utilizes specialized magnets to align tissue and form a secure connection without leaving permanent foreign materials like staples or sutures, which can impede natural healing. The CEO of GT Metabolic Solutions described the clearance as a pivotal moment for introducing less invasive surgical techniques that aim to minimize complications such as bleeding and leakage in bariatric and digestive health procedures.
• In May 2024, Ethicon, a subsidiary of Johnson & Johnson MedTech, announced the United States launch of the ECHELON LINEAR Cutter, a significant advancement in the surgical stapling market. This device was described as the first linear cutter to combine proprietary 3D-Stapling Technology with Gripping Surface Technology, features designed to enhance staple line security and tissue integrity. The company highlighted that the stapler demonstrated a 47% reduction in leaks at the staple line compared to standard devices, directly addressing critical risks such as anastomotic leaks in colorectal surgery. The Global President of Ethicon Energy and Endomechanical stated that the innovation aimed to provide surgeons with superior control when navigating complex anatomy.

Key Market Players

• Medtronic plc
• Johnson & Johnson Services, Inc.
• Baxter International Inc.
• Boston Scientific Corporation
• Stryker Corporation
• Teleflex Incorporated
• Cook Medical LLC
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• Terumo Corporation

By Product	By Application	By End-use	By Region
Disposable Reusable	Cardiovascular Surgery Gastrointestinal Surgery Others	Hospitals Ambulatory Care Centers & Clinics	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Anastomosis Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Anastomosis Devices Market, By Product:

• Disposable
• Reusable

• Anastomosis Devices Market, By Application:

• Cardiovascular Surgery
• Gastrointestinal Surgery
• Others

• Anastomosis Devices Market, By End-use:

• Hospitals
• Ambulatory Care Centers & Clinics

• Anastomosis Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE